Risk of prion disease transmission from ocular donor tissue transplantation

Cornea

Volumn 18, Issue 1, 1999, Pages 2-11

  Hogan, R Nick ^a   Brown, Paul ^b   Heck, Ellen ^a   Cavanagh, H Dwight ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b National Institute of Neurological Disorders and Stroke   (United States)

Author keywords

Corneal transplant; Creutzfeldt; Jakob disease; Mad cow disease; Prion disease

Indexed keywords

ARTICLE; BOVINE SPONGIFORM ENCEPHALOPATHY; CEREBELLUM DISEASE; CLINICAL FEATURE; COGNITIVE DEFECT; CORNEA TRANSPLANTATION; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; HUMAN; INFECTION RISK; MYOCLONUS; PRION DISEASE; PRIORITY JOURNAL; SCREENING TEST; SPEECH DISORDER; UNITED STATES;

EID: 0032948013     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-199901000-00002     Document Type: Article

References (49)

1. Power H. On transplantation of the cornea. Rep Int Ophthalmol Congr London 1973;4:172-6.
2. EBAA eye banking statistical report. Washington, DC: EBAA, 1997.
3. Duffy P. Wolf J, Collins G, DeVoe AG, Streen B, Cowen D. Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med 1974;290:692-3.
4. Heckmann JG, Lang CJG, Petruch F, et al. Transmission of Creutzfeldt-Jakob disease via a corneal transplant. J Neurol Neurosurg Psychiatry 1997;63:388-90.
5. Uchiyama K, Ishida C, Yago S, Kuramaya H, Kitmoto T. An autopsy case of Creutzfeldt-Jakob disease associated with corneal transplantation. Dementia 1994;8:466-73.
6. Brown P, Cervenakova L, Goldfarb LG, et al. Iatrogenic Creutzfeldt-Jakob disease: an example of the interplay between ancient genes and modern medicine. Neurology 1994;44:291-3.
7. Brown P, Gibbs CL, Rodgers-Johnson P, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimental transmitted disease. Ann Neurol 1994;35: 513-29.
8. Hogan RN, Cavanagh HD. Transplantation of corneal tissue from donors with diseases of the central nervous system. Cornea 1995; 14:547-53.
9. Zerr I, Bodemer M, Racker S, et al. Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease. Lancet 1995;345:1609-10.
10. Holman RC, Khan AS, Belay ED, Schonberger LB. Creutzfeldt-Jakob disease in the United States, 1979-1994: using national mortality data to assess the possible occurrence of variant cases. Emerg Infect Dis 1996;2:333-7.
11. US Bureau of the Census. United States population estimates by age, sex, race, and national origin, 1990-1997. Release PPL-91. Washington, DC: U.S. Government Printing Office, 1998.
12. Busch MP, Glynn SA, Schreiber GB. Potential increased risk of virus transmission due to exclusion of older donors because of concern over Creutzfeldt-Jakob disease. Transfusion 1997;37:996-1002.
13. Brown P. Donor pool size and the risk of blood-borne Creutzfeldt-Jakob disease. Transfusion 1998;38:312-5.
14. Will RG, Matthews WB. A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-1979 I: clinical features. J Neurol Neurosurg Psychiatry 1984;47:134-40.
15. Traub R, Gajdusek DC, Gibbs CJ. Transmissible virus dementia: the relation of transmissible spongiform encephalopathy to Creutzfeldt-Jakob disease. In: Smith WI, Kinsbourne M, eds. Aging and dementia. New York: Spectrum Press, 1977:91-172.
16. Brown P, Cathala F, Castaigne P, Gajdusek DC. Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol 1986;20:597-602.
17. De Silva R. Human spongiform encephalopathy: clinical presentation and diagnostic tests. In: Baker H, Ridley RM, eds. Methods in molecular medicine: prion disease. Totowa, NJ: Humana Press, 1996:15-33.
18. Masters CL, Harris JO, Gajdusek DC, Gibbs CL, Bernoulli C, Asher DM. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 1979;5:177-88.
19. Uchino A, Yoshinaga M, Shiokawa O, Hata H, Ohno M. Serial MR imaging in Creutzfeldt-Jakob disease. Neuroradiology 1991; 33:364-7.
20. Milton WJ, Atlas SW, Lavi E, Mollman JE. Magnetic resonance imaging of Creutzfeldt-Jakob disease. Ann Neurol 1991;29:438-40.
21. Onofrj M, Fulgente T, Gambi D, Macchi G. Early MRI findings in Creutzfeldt-Jakob disease. J Neurol 1993;240:423-6.
22. Eye Bank Association of America, Medical Standards 1994:9.
23. Harrington NG, Merril CR, Asher DM, Gajdusek DC. Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. N Engl J Med 1986;315:279-83.
24. Blisard KS, Davis LE, Harrington MG, Lovell JK, Kornfield M, Berger ML. Pre-mortem diagnosis of Creutzfeldt-Jakob disease by detection of abnormal cerebrospinal fluid proteins. J Neurol Sci 1990;99:75-81.
25. Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathy. N Engl J Med 1996;355: 924-30.
26. Lee KH, Harrington MG. The assay development of a molecular marker for transmissible spongiform encephalopathies. Electrophoresis 1997;18:502-6.
27. Lee KH, Harrington M.: Pre-mortem diagnosis of Creutzfeldt-Jakob disease by cerebrospinal fluid analysis. Lancet 1996;348: 887.
28. Collinge J. New diagnostic tests for prion diseases. N Engl J Med 1996;335:963-5.
29. Otto M, Wiltfang J, Schutz E, et al. Diagnosis of Creutzfeldt-Jakob disease by measurement of S-100 protein in serum: prospective case-control study. Br Med J 1998;316:577-82.
30. Bell J. Neuropathological diagnosis of human prion diseases. PrP immunocytochemical techniques. In: Baker H, Ridley RM, eds. Methods in molecular medicine: prion disease. Totowa, NJ: Humana, 1996:15-33.
31. Kretzschmar HA, Ironside JW, DeArmond SJ, Tateishi J. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol 1995;53:913-20.
32. Tateishi J, Kitamoto T, Kretzschmar H, Mehraein P. Immunohistological evaluation of Creutzfeldt-Jakob disease with reference to the type PrPres deposition. Clin Neuropathol 1996;15:358-60.
33. Wilesmith JW, Wells GAH. Bovine spongiform encephalopathy. Curr Topics Microbiol Immunol 1991;172:21-38.
34. Wells GAH, Scott AC, Johnson CT, et al. A novel progressive spongiform encephalopathy in cattle. Vet Rec 1987;121:419-20.
35. Wells GAH, Wilesmith JW. The distribution pattern of neuronal vacuolation in bovine spongiform encephalopathy (BSE) is constant. Neuropathol Appl Neurobiol 1989;15:591.
36. Willesmith JW, Ryan JBM, Atkinson MJ. Bovine spongiform encephalopathy: epidemiological studies on the origin. Vet Rec 1991; 123:199-203.
37. Willesmith JW. Bovine spongiform encephalopathy: methods of analyzing the epidemic in the United Kingdom. In: Baker H, Ridley RM, eds. Methods in molecular medicine: prion diseases. Totowa, NJ: Humana, 1996:155-73.
38. Tyrell DAJ, Taylor KC. Handling the BSE epidemic in Great Britain. In: Baker H, Ridley RM, eds. Methods in molecular medicine: prion diseases. Totowa, NJ: Humana, 1996:155-73.
39. Meslin FX. Global aspects of emerging and potential zoonoses: a WHO perspective. Emerg Infect Dis 1997;3:223-8.
40. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921-5.
41. Lasmezas CI, Deslys JP, Demaimay R, Adjou KT, Lamoury F, Dormont D. BSE transmission to macaques. Nature 1996;381: 743-41.
42. Bruce ME, Will RG, Ironside JW, et al: Transmissions to mice indicate that "new variant" CJD is caused by the BSE agent. Nature 1997;389:498-501.
43. Collinge J, Sidle KCL, Heads J, et al. Molecular analysis of prion strain variation and the aetiology of "new variant" CJD. Nature 1996;383:685-90.
44. Hill AF, Desbruslais M, Joiner S, et al. The same prion strain causes vCJD and BSE. Nature 1997;389:448-50.
45. Brown P. The risk of bovine spongiform encephalopathy ("mad cow disease") to human health. JAMA 1997;278:1008-11.
46. Raymond GJ, Hope J, Kocisko DA, et al. Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature 1997:388:285-8.
47. Pocchiari M. Early identification of variant Creutzfeldt-Jakob disease [Editorial]. Br Med J 1998;316:563-4.
48. Chazot G, Broussole E, Lapras CI, Blattler I, Aguzzi A, Kopp N. New variant of Creutzfeldt-Jakob disease in a 26 year-old French man. Lancet 1996;347:1181.
49. Ironside JW. Neuropathological diagnosis of human prion disease: morphological studies. In: Baker H, Ridley RM, eds. Methods in molecular medicine: prion diseases. Totowa, NJ: Humana, 1996:49.